About Seyed-Al-Shohada Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Seyed-Al-Shohada Hospital
During the past decade, Seyed-Al-Shohada Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
2006-07-28
2023-12-01
Active, not recruiting
790
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
2008-12-01
2016-12-01
Completed
59
Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
2008-09-03
2016-02-25
Completed
723
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Seyed-Al-Shohada Hospital
According to Clinical.Site data, the most researched conditions in "Seyed-Al-Shohada Hospital" are
"Congenital Fibrinogen Deficiency" (1 trials) and "HER2-positive Breast Cancer" (1 trials). Many other conditions were trialed in "Seyed-Al-Shohada Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Seyed-Al-Shohada Hospital
Most popular intervention types in "Seyed-Al-Shohada Hospital" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (1 trials), "Docetaxel" (1 trials), "Octafibrin" (1 trials), "Pertuzumab" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Seyed-Al-Shohada Hospital
The vast majority of trials in "Seyed-Al-Shohada Hospital" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Seyed-Al-Shohada Hospital
Currently, there are NaN active trials in "Seyed-Al-Shohada Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Seyed-Al-Shohada Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Seyed-Al-Shohada Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".